Watch as Prof Steven Pipe, University of Michigan, talks about his role as a Scientific Committee Member in the Prof Heimburger Award process and shares advice on applying. The Prof Heimburger Award has been established to honor the achievements of Prof Dr. Norbert Heimburger in pioneering modern coagulation therapy during his 30 years at CSL Behring. In the 18 years of its running, 85 promising coagulations specialists from all over the world have benefited from receiving the Prof Heimburger Award grant. This year again, 5 early-career specialists will be awarded €25,000 grants to support their innovative coagulation research. If you think that this could be you, simply submit your proposal through the Prof Heimburger Award website. Applications must be received by 11:59pm CET, November 11, 2024 to be considered. Please be aware that applications must meet eligibility criteria. See here for details: https://bit.ly/3Ts5mG1
Now Accepting Applications for the 2025 Prof Heimburger Awards
CSL offers emerging coagulation specialists five global start-up grants of $25,000 each.
Pictured: CSL Seqirus employee in Holly Springs, U.S.
We have released our 2024 Annual Report Click here to read the Annual Report → | We have announced our 2024 Full Year Financial Results for the period ending June 30th 2024. Click here to view Information and Webcast Recording →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL BehringCSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL SeqirusCSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: CSL employees in Melbourne, Australia